AJPhar SRL
AJPhar reported total assets of 6,429 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Oct 2026).
The score of AJPhar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -72 % Total assets -64 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AJPhar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Oct 2026
- Year ended 31 Dec 2024filed on 22 Sep 2025
- Year ended 31 Dec 2023filed on 24 Aug 2024
- Year ended 31 Dec 2022filed on 22 May 2023
AJPhar's financial analysis
- Solvency32.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AJPhar
AJPhar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0778.569.213
- VAT number
- BE0778569213
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 13 Dec 2021
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 11 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AJPhar (SRL) has been based in Waterloo since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 9,013 € and equity of 2,104 €; its revenue is not published. Its solvency stands at 32.7%, below the median of its sector (41.5%).
Companies similar to AJPhar
Companies in the same business, of comparable size and area, outside its group.
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- Smilla Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet 70,168 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
Frequently asked questions about AJPhar
What is the revenue of AJPhar?
AJPhar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AJPhar?
In Belgium, the VAT number is the company number prefixed with BE: BE0778569213 for AJPhar, if the company is VAT-registered. Its company number (CBE) is 0778.569.213.
Where is the registered office of AJPhar?
According to the CBE register, the registered office of AJPhar is in 1410 Waterloo.
What is the equity of AJPhar?
At the close of the 2025 financial year, the equity of AJPhar amounts to 2,104 €, a solvency of 32.7% of total assets.
Who manages AJPhar?
The register lists 1 active mandates at AJPhar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AJPhar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →